Attention deficit hyperactivity disorder: diagnosis and management

Supporting evidence

• Surveillance report

• September 2024 exceptional surveillance of attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87)

• 2021 exceptional surveillance of attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87)

• Other supporting evidence

• Methods (PDF 1.15 MB)

  Published:

  16 March 2018

• Appendix 1: parent training model write-up (PDF 1.65 MB)

  Published:

  14 March 2018

• Appendix 2: Children combo model write-up (PDF 2.17 MB)

  Published:

  14 March 2018

• Appendix 3: NMA write-up (PDF 682 KB)

  Published:

  14 March 2018

• Evidence review

• A: Risk factors (PDF 1.8 MB)

  Published:

  13 September 2019

• B: Information and support (PDF 3.88 MB)

  Published:

  13 September 2019

• C: Pharmacological efficacy and sequencing (PDF 14.67 MB)

  Published:

  13 September 2019

• D: Pharmacological safety (PDF 7.57 MB)

  Published:

  13 September 2019

• E: Non-pharmacological efficacy and adverse events (PDF 11.04 MB)

  Published:

  13 September 2019

• F: Combination treatment (PDF 8.44 MB)

  Published:

  13 September 2019

• G: Adherence to treatment (PDF 2.08 MB)

  Published:

  13 September 2019

• H: Managing treatment (PDF 3.38 MB)

  Published:

  13 September 2019

• I: Withdrawal and drug holidays (PDF 2.57 MB)

  Published:

  13 September 2019

• Evidence reviews – March 2018

• Evidence review – February 2016

• Dietary interventions (PDF 1.42 MB)

  Published:

  17 February 2016

• Full guidance

• Full guideline – September 2008

• Full guideline (PDF 8.91 MB)

  Published:

  19 September 2008

• Appendices 1–6 (PDF 787 KB)

  Published:

  19 September 2008

• Appendices 7–8 (PDF 976 KB)

  Published:

  19 September 2008

• Appendices 9–10 (PDF 590 KB)

  Published:

  19 September 2008